Analysen von Michael Leuchten

27.09.18 GSK buy UBS AG
18.09.18 Bayer buy UBS AG
05.09.18 Bayer buy UBS AG
30.08.18 Bayer buy UBS AG
17.08.18 Bayer buy UBS AG
09.08.18 Merck buy UBS AG
08.08.18 Novo Nordisk buy UBS AG
03.08.18 GSK buy UBS AG
30.07.18 GSK buy UBS AG
26.07.18 GSK buy UBS AG
25.07.18 Novo Nordisk buy UBS AG
25.07.18 GSK buy UBS AG
23.07.18 GSK buy UBS AG
02.07.18 GSK buy UBS AG
26.06.18 Bayer buy UBS AG
26.06.18 Merck buy UBS AG
25.06.18 Novo Nordisk buy UBS AG
14.06.18 GSK buy UBS AG
14.06.18 Novo Nordisk buy UBS AG
08.06.18 Novo Nordisk buy UBS AG
06.06.18 Bayer buy UBS AG
31.05.18 Bayer buy UBS AG
30.05.18 Novo Nordisk buy UBS AG
30.05.18 Bayer buy UBS AG
25.05.18 GSK buy UBS AG
17.05.18 Merck buy UBS AG
15.05.18 Merck buy UBS AG
03.05.18 Bayer buy UBS AG
03.05.18 Novo Nordisk buy UBS AG
02.05.18 Novo Nordisk buy UBS AG
26.04.18 GSK buy UBS AG
25.04.18 Novo Nordisk buy UBS AG
05.04.18 GSK buy UBS AG
04.04.18 Merck Buy UBS AG
27.03.18 GSK buy UBS AG
27.03.18 Novo Nordisk buy UBS AG
22.03.18 Bayer buy UBS AG
12.03.18 Merck buy UBS AG
08.03.18 Merck buy UBS AG
28.02.18 Bayer buy UBS AG
19.02.18 Novo Nordisk buy UBS AG
16.02.18 Merck buy UBS AG
14.02.18 Bayer buy UBS AG
12.02.18 Bayer buy UBS AG
08.02.18 GSK buy UBS AG
07.02.18 Novo Nordisk buy UBS AG
02.02.18 Novo Nordisk buy UBS AG
01.02.18 Novo Nordisk buy UBS AG
15.01.18 Novo Nordisk buy UBS AG
15.01.18 Merck buy UBS AG